362 related articles for article (PubMed ID: 33971116)
21. Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.
Haber PS; Elsayed M; Espinoza D; Lintzeris N; Veillard AS; Hallinan R
Drug Alcohol Depend; 2017 Dec; 181():132-139. PubMed ID: 29054032
[TBL] [Abstract][Full Text] [Related]
22. Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
[TBL] [Abstract][Full Text] [Related]
23. Mental Health Distress Is Associated With Higher Pain Interference in Patients With Opioid Use Disorder Stabilized on Buprenorphine or Methadone.
Leyde S; Price CJ; Colgan DD; Pike KC; Tsui JI; Merrill JO
Subst Use Addctn J; 2024 Jul; 45(3):423-433. PubMed ID: 38327009
[TBL] [Abstract][Full Text] [Related]
24. Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses.
Bretteville-Jensen AL; Lillehagen M; Gjersing L; Andreas JB
Drug Alcohol Depend; 2015 Feb; 147():89-96. PubMed ID: 25543167
[TBL] [Abstract][Full Text] [Related]
25. DYNAMICS OF OPIOID SUBSTITUTION TREATMENTIN DIFFERENT INITIAL SUBSTANCE USER OPIOID DEPENDENT PATIENTS.
Todadze Kh; Mosia S
Georgian Med News; 2016 May; (254):56-61. PubMed ID: 27348169
[TBL] [Abstract][Full Text] [Related]
26. Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine.
Heikman PK; Muhonen LH; Ojanperä IA
BMC Psychiatry; 2017 Jul; 17(1):245. PubMed ID: 28683783
[TBL] [Abstract][Full Text] [Related]
27. Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment.
Casati A; Piontek D; Pfeiffer-Gerschel T
Subst Abuse Treat Prev Policy; 2014 May; 9():19. PubMed ID: 24885218
[TBL] [Abstract][Full Text] [Related]
28. [Buprenorphine or methadone for detoxification of young opioid addicts?].
Ebner R; Schreiber W; Zierer C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
[TBL] [Abstract][Full Text] [Related]
29. Prolonged use of benzodiazepines is associated with childhood trauma in opioid-maintained patients.
Vogel M; Dürsteler-Macfarland KM; Walter M; Strasser J; Fehr S; Prieto L; Wiesbeck GA
Drug Alcohol Depend; 2011 Dec; 119(1-2):93-8. PubMed ID: 21715105
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.
Toce MS; Chai PR; Burns MM; Boyer EW
J Med Toxicol; 2018 Dec; 14(4):306-322. PubMed ID: 30377951
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with buprenorphine versus methadone use in pregnancy.
Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
[TBL] [Abstract][Full Text] [Related]
32. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
33. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
34. Comparison of buprenorphine and methadone maintenance in opiate addicts.
Eder H; Fischer G; Gombas W; Jagsch R; Stühlinger G; Kasper S
Eur Addict Res; 1998; 4 Suppl 1():3-7. PubMed ID: 9767199
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China.
Yin W; Pang L; Cao X; McGoogan JM; Liu M; Zhang C; Li Z; Li J; Rou K
Addiction; 2015 Jan; 110 Suppl 1():51-60. PubMed ID: 25533864
[TBL] [Abstract][Full Text] [Related]
36. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.
Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Edwards RR; Samet JH
Drug Alcohol Depend; 2016 Sep; 166():26-31. PubMed ID: 27422763
[TBL] [Abstract][Full Text] [Related]
37. Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis.
Xu KY; Borodovsky JT; Presnall N; Mintz CM; Hartz SM; Bierut LJ; Grucza RA
Am J Psychiatry; 2021 Jul; 178(7):651-659. PubMed ID: 33653119
[TBL] [Abstract][Full Text] [Related]
38. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.
Rapeli P; Fabritius C; Kalska H; Alho H
BMC Clin Pharmacol; 2011 Aug; 11():13. PubMed ID: 21854644
[TBL] [Abstract][Full Text] [Related]
39. Use and misuse of opioid agonists in opioid addiction.
Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
[TBL] [Abstract][Full Text] [Related]
40. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
